1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cholangitis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Acute Cholangitis
        1.2.3 Primary Sclerosing Cholangitis
        1.2.4 Secondary Sclerosing Cholangitis
        1.2.5 Recurrent Pyogenic Cholangitis
    1.3 Market by Application
        1.3.1 Global Cholangitis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Clinical Practise
        1.3.3 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cholangitis Market Perspective (2017-2028)
    2.2 Cholangitis Growth Trends by Region
        2.2.1 Cholangitis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cholangitis Historic Market Size by Region (2017-2022)
        2.2.3 Cholangitis Forecasted Market Size by Region (2023-2028)
    2.3 Cholangitis Market Dynamics
        2.3.1 Cholangitis Industry Trends
        2.3.2 Cholangitis Market Drivers
        2.3.3 Cholangitis Market Challenges
        2.3.4 Cholangitis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cholangitis Players by Revenue
        3.1.1 Global Top Cholangitis Players by Revenue (2017-2022)
        3.1.2 Global Cholangitis Revenue Market Share by Players (2017-2022)
    3.2 Global Cholangitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cholangitis Revenue
    3.4 Global Cholangitis Market Concentration Ratio
        3.4.1 Global Cholangitis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cholangitis Revenue in 2021
    3.5 Cholangitis Key Players Head office and Area Served
    3.6 Key Players Cholangitis Product Solution and Service
    3.7 Date of Enter into Cholangitis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cholangitis Breakdown Data by Type
    4.1 Global Cholangitis Historic Market Size by Type (2017-2022)
    4.2 Global Cholangitis Forecasted Market Size by Type (2023-2028)
5 Cholangitis Breakdown Data by Application
    5.1 Global Cholangitis Historic Market Size by Application (2017-2022)
    5.2 Global Cholangitis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cholangitis Market Size (2017-2028)
    6.2 North America Cholangitis Market Size by Type
        6.2.1 North America Cholangitis Market Size by Type (2017-2022)
        6.2.2 North America Cholangitis Market Size by Type (2023-2028)
        6.2.3 North America Cholangitis Market Share by Type (2017-2028)
    6.3 North America Cholangitis Market Size by Application
        6.3.1 North America Cholangitis Market Size by Application (2017-2022)
        6.3.2 North America Cholangitis Market Size by Application (2023-2028)
        6.3.3 North America Cholangitis Market Share by Application (2017-2028)
    6.4 North America Cholangitis Market Size by Country
        6.4.1 North America Cholangitis Market Size by Country (2017-2022)
        6.4.2 North America Cholangitis Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Cholangitis Market Size (2017-2028)
    7.2 Europe Cholangitis Market Size by Type
        7.2.1 Europe Cholangitis Market Size by Type (2017-2022)
        7.2.2 Europe Cholangitis Market Size by Type (2023-2028)
        7.2.3 Europe Cholangitis Market Share by Type (2017-2028)
    7.3 Europe Cholangitis Market Size by Application
        7.3.1 Europe Cholangitis Market Size by Application (2017-2022)
        7.3.2 Europe Cholangitis Market Size by Application (2023-2028)
        7.3.3 Europe Cholangitis Market Share by Application (2017-2028)
    7.4 Europe Cholangitis Market Size by Country
        7.4.1 Europe Cholangitis Market Size by Country (2017-2022)
        7.4.2 Europe Cholangitis Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cholangitis Market Size (2017-2028)
    8.2 Asia-Pacific Cholangitis Market Size by Type
        8.2.1 Asia-Pacific Cholangitis Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Cholangitis Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Cholangitis Market Share by Type (2017-2028)
    8.3 Asia-Pacific Cholangitis Market Size by Application
        8.3.1 Asia-Pacific Cholangitis Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Cholangitis Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Cholangitis Market Share by Application (2017-2028)
    8.4 Asia-Pacific Cholangitis Market Size by Region
        8.4.1 Asia-Pacific Cholangitis Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Cholangitis Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Cholangitis Market Size (2017-2028)
    9.2 Latin America Cholangitis Market Size by Type
        9.2.1 Latin America Cholangitis Market Size by Type (2017-2022)
        9.2.2 Latin America Cholangitis Market Size by Type (2023-2028)
        9.2.3 Latin America Cholangitis Market Share by Type (2017-2028)
    9.3 Latin America Cholangitis Market Size by Application
        9.3.1 Latin America Cholangitis Market Size by Application (2017-2022)
        9.3.2 Latin America Cholangitis Market Size by Application (2023-2028)
        9.3.3 Latin America Cholangitis Market Share by Application (2017-2028)
    9.4 Latin America Cholangitis Market Size by Country
        9.4.1 Latin America Cholangitis Market Size by Country (2017-2022)
        9.4.2 Latin America Cholangitis Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cholangitis Market Size (2017-2028)
    10.2 Middle East & Africa Cholangitis Market Size by Type
        10.2.1 Middle East & Africa Cholangitis Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Cholangitis Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Cholangitis Market Share by Type (2017-2028)
    10.3 Middle East & Africa Cholangitis Market Size by Application
        10.3.1 Middle East & Africa Cholangitis Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Cholangitis Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Cholangitis Market Share by Application (2017-2028)
    10.4 Middle East & Africa Cholangitis Market Size by Country
        10.4.1 Middle East & Africa Cholangitis Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Cholangitis Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Taiho Pharmaceutical
        11.1.1 Taiho Pharmaceutical Company Details
        11.1.2 Taiho Pharmaceutical Business Overview
        11.1.3 Taiho Pharmaceutical Cholangitis Introduction
        11.1.4 Taiho Pharmaceutical Revenue in Cholangitis Business (2017-2022)
        11.1.5 Taiho Pharmaceutical Recent Developments
    11.2 Mayo Clinic
        11.2.1 Mayo Clinic Company Details
        11.2.2 Mayo Clinic Business Overview
        11.2.3 Mayo Clinic Cholangitis Introduction
        11.2.4 Mayo Clinic Revenue in Cholangitis Business (2017-2022)
        11.2.5 Mayo Clinic Recent Developments
    11.3 Bayer
        11.3.1 Bayer Company Details
        11.3.2 Bayer Business Overview
        11.3.3 Bayer Cholangitis Introduction
        11.3.4 Bayer Revenue in Cholangitis Business (2017-2022)
        11.3.5 Bayer Recent Developments
    11.4 Gilead Sciences
        11.4.1 Gilead Sciences Company Details
        11.4.2 Gilead Sciences Business Overview
        11.4.3 Gilead Sciences Cholangitis Introduction
        11.4.4 Gilead Sciences Revenue in Cholangitis Business (2017-2022)
        11.4.5 Gilead Sciences Recent Developments
    11.5 RiemserArzneimittel
        11.5.1 RiemserArzneimittel Company Details
        11.5.2 RiemserArzneimittel Business Overview
        11.5.3 RiemserArzneimittel Cholangitis Introduction
        11.5.4 RiemserArzneimittel Revenue in Cholangitis Business (2017-2022)
        11.5.5 RiemserArzneimittel Recent Developments
    11.6 Zambon
        11.6.1 Zambon Company Details
        11.6.2 Zambon Business Overview
        11.6.3 Zambon Cholangitis Introduction
        11.6.4 Zambon Revenue in Cholangitis Business (2017-2022)
        11.6.5 Zambon Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Cholangitis Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Acute Cholangitis
    Table 3. Key Players of Primary Sclerosing Cholangitis
    Table 4. Key Players of Secondary Sclerosing Cholangitis
    Table 5. Key Players of Recurrent Pyogenic Cholangitis
    Table 6. Global Cholangitis Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Cholangitis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cholangitis Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cholangitis Market Share by Region (2017-2022)
    Table 10. Global Cholangitis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cholangitis Market Share by Region (2023-2028)
    Table 12. Cholangitis Market Trends
    Table 13. Cholangitis Market Drivers
    Table 14. Cholangitis Market Challenges
    Table 15. Cholangitis Market Restraints
    Table 16. Global Cholangitis Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cholangitis Revenue Share by Players (2017-2022)
    Table 18. Global Top Cholangitis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholangitis as of 2021)
    Table 19. Ranking of Global Top Cholangitis Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cholangitis Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cholangitis Product Solution and Service
    Table 23. Date of Enter into Cholangitis Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cholangitis Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cholangitis Revenue Market Share by Type (2017-2022)
    Table 27. Global Cholangitis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cholangitis Revenue Market Share by Type (2023-2028)
    Table 29. Global Cholangitis Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cholangitis Revenue Share by Application (2017-2022)
    Table 31. Global Cholangitis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cholangitis Revenue Share by Application (2023-2028)
    Table 33. North America Cholangitis Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Cholangitis Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Cholangitis Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Cholangitis Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Cholangitis Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Cholangitis Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Cholangitis Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Cholangitis Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Cholangitis Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Cholangitis Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Cholangitis Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Cholangitis Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Cholangitis Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Cholangitis Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Cholangitis Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Cholangitis Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Cholangitis Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Cholangitis Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Cholangitis Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Cholangitis Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Cholangitis Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Cholangitis Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Cholangitis Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Cholangitis Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Cholangitis Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Cholangitis Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Cholangitis Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Cholangitis Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Cholangitis Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Cholangitis Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Taiho Pharmaceutical Company Details
    Table 64. Taiho Pharmaceutical Business Overview
    Table 65. Taiho Pharmaceutical Cholangitis Product
    Table 66. Taiho Pharmaceutical Revenue in Cholangitis Business (2017-2022) & (US$ Million)
    Table 67. Taiho Pharmaceutical Recent Developments
    Table 68. Mayo Clinic Company Details
    Table 69. Mayo Clinic Business Overview
    Table 70. Mayo Clinic Cholangitis Product
    Table 71. Mayo Clinic Revenue in Cholangitis Business (2017-2022) & (US$ Million)
    Table 72. Mayo Clinic Recent Developments
    Table 73. Bayer Company Details
    Table 74. Bayer Business Overview
    Table 75. Bayer Cholangitis Product
    Table 76. Bayer Revenue in Cholangitis Business (2017-2022) & (US$ Million)
    Table 77. Bayer Recent Developments
    Table 78. Gilead Sciences Company Details
    Table 79. Gilead Sciences Business Overview
    Table 80. Gilead Sciences Cholangitis Product
    Table 81. Gilead Sciences Revenue in Cholangitis Business (2017-2022) & (US$ Million)
    Table 82. Gilead Sciences Recent Developments
    Table 83. RiemserArzneimittel Company Details
    Table 84. RiemserArzneimittel Business Overview
    Table 85. RiemserArzneimittel Cholangitis Product
    Table 86. RiemserArzneimittel Revenue in Cholangitis Business (2017-2022) & (US$ Million)
    Table 87. RiemserArzneimittel Recent Developments
    Table 88. Zambon Company Details
    Table 89. Zambon Business Overview
    Table 90. Zambon Cholangitis Product
    Table 91. Zambon Revenue in Cholangitis Business (2017-2022) & (US$ Million)
    Table 92. Zambon Recent Developments
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cholangitis Market Share by Type: 2021 VS 2028
    Figure 2. Acute Cholangitis Features
    Figure 3. Primary Sclerosing Cholangitis Features
    Figure 4. Secondary Sclerosing Cholangitis Features
    Figure 5. Recurrent Pyogenic Cholangitis Features
    Figure 6. Global Cholangitis Market Share by Application: 2021 VS 2028
    Figure 7. Clinical Practise Case Studies
    Figure 8. Others Case Studies
    Figure 9. Cholangitis Report Years Considered
    Figure 10. Global Cholangitis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Cholangitis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cholangitis Market Share by Region: 2021 VS 2028
    Figure 13. Global Cholangitis Market Share by Players in 2021
    Figure 14. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholangitis as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Cholangitis Revenue in 2021
    Figure 16. North America Cholangitis Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Cholangitis Market Size Market Share by Type (2017-2028)
    Figure 18. North America Cholangitis Market Size Market Share by Application (2017-2028)
    Figure 19. North America Cholangitis Market Size Share by Country (2017-2028)
    Figure 20. United States Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Cholangitis Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Cholangitis Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Cholangitis Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Cholangitis Market Size Share by Country (2017-2028)
    Figure 26. Germany Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cholangitis Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Cholangitis Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Cholangitis Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Cholangitis Market Size Share by Region (2017-2028)
    Figure 36. China Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Cholangitis Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Cholangitis Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Cholangitis Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Cholangitis Market Size Share by Country (2017-2028)
    Figure 46. Mexico Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Cholangitis Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Cholangitis Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Cholangitis Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Cholangitis Market Size Share by Country (2017-2028)
    Figure 52. Turkey Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Cholangitis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Taiho Pharmaceutical Revenue Growth Rate in Cholangitis Business (2017-2022)
    Figure 56. Mayo Clinic Revenue Growth Rate in Cholangitis Business (2017-2022)
    Figure 57. Bayer Revenue Growth Rate in Cholangitis Business (2017-2022)
    Figure 58. Gilead Sciences Revenue Growth Rate in Cholangitis Business (2017-2022)
    Figure 59. RiemserArzneimittel Revenue Growth Rate in Cholangitis Business (2017-2022)
    Figure 60. Zambon Revenue Growth Rate in Cholangitis Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed